Cushing’s syndrome is a rare endocrine illness. Although its reported incidence is about 10 cases per million people each year, it is estimated to be much higher in subclinical scenarios. It can lead to several pathologies such as diabetes, hypertension, high triglycerides, blood clots, osteoporosis, muscle loss and cardiovascular mortality.
The current study adds obstructive sleep apnea as another possible complication of CS, independent of age, gender, body mass index and insulin resistance.
Should patients with obstructive sleep apnea be screened for subclinical cushing’s syndrome?